Publicaciones en colaboración con investigadores/as de University of Melbourne (19)

2024

  1. Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

2023

  1. Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors

    Human gene therapy, Vol. 34, Núm. 7-8, pp. 273-288

2022

  1. Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers

    ESMO Open, Vol. 7, Núm. 2

  2. Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE

    Blood, Vol. 139, Núm. 4, pp. 492-501

2020

  1. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1

2018

  1. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays

    Parasites and Vectors, Vol. 11, Núm. 1

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

2014

  1. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33

    Human Molecular Genetics, Vol. 23, Núm. 24, pp. 6616-6633

2013

  1. Genome-wide association study identifies two susceptibility loci for osteosarcoma

    Nature Genetics, Vol. 45, Núm. 7, pp. 799-803

2012

  1. Detectable clonal mosaicism and its relationship to aging and cancer

    Nature Genetics, Vol. 44, Núm. 6, pp. 651-658

  2. New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women

    Journal of Infectious Diseases, Vol. 206, Núm. 10, pp. 1612-1621

  3. Virotherapy, gene transfer and immunostimulatory monoclonal antibodies

    OncoImmunology, Vol. 1, Núm. 8, pp. 1344-1354

2011

  1. Differentiation of inflammatory dendritic cells is mediated by NF-κB1-dependent GM-CSF production in CD4 T cells

    Journal of Immunology, Vol. 186, Núm. 9, pp. 5468-5477

  2. Identifying polyglutamine protein species in situ that best predict neurodegeneration

    Nature Chemical Biology, Vol. 7, Núm. 12, pp. 925-934

2010

  1. Evaluation of the antigenic diversity of placenta-binding plasmodium falciparum variants and the antibody repertoire among pregnant women

    Infection and Immunity, Vol. 78, Núm. 5, pp. 1963-1978

2009

  1. Distribution of relaxin-3 mRNA and immunoreactivity and RXFP3-binding sites in the brain of the macaque, macaca fascicularis

    Annals of the New York Academy of Sciences

  2. Localization of relaxin-3 in brain of Macaca fascicularis: Identification of a nucleus incertus in primate

    Journal of Comparative Neurology, Vol. 517, Núm. 6, pp. 856-872

  3. Sir2 paralogues cooperate to regulate virulence genes and antigenic variation in Plasmodium falciparum

    PLoS Biology, Vol. 7, Núm. 4, pp. 0771-0788

2007

  1. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data

    Nature Protocols, Vol. 2, Núm. 9, pp. 2057-2067